Point Mutations in Exon 1B of APC Reveal Gastric Adenocarcinoma and Proximal Polyposis of the Stomach as a Familial Adenomatous Polyposis Variant
Jun Li, Susan L Woods, Sue Healey, Jonathan Beesley, Xiaoqing Chen, Jason S Lee, Haran Sivakumaran, Nicci Wayte, Katia Nones, Joshua J Waterfall, John Pearson, Anne-Marie Patch, Janine Senz, Manuel A Ferreira, Pardeep Kaurah, Robertson Mackenzie, Alireza Heravi-Moussavi, Samantha Hansford, Tamsin RM Lannagan, Amanda B Spurdle Show all
The American Journal of Human Genetics | CELL PRESS | Published : 2016
Awarded by NIH
Awarded by Canadian Institutes of Health Research
Awarded by NHMRC
We thank all the individuals from the GAPPS-affected families who took part in this study, Andrew Giraud for providing the AGS and MKN74 cell lines, and Vicki Whitehall for HCT116 and RKO. The work was funded by the NHMRC, NIH (PO1-CA073992), and grant MOP-123517 from the Canadian Institutes of Health Research and the Ride to Conquer Cancer. G.J.F. acknowledges the support of an NHMRC Career Development Fellowship (GNT1045237); D.L.W., T.R.M.L., and S.L.W. are funded by Cancer Council South Australia Beat Cancer Project; G.C.-T. and A.B.S. by NHMRC Research Fellowships; and K.A.S. by the Canadian Institutes of Health Research, Michael Smith Foundation for Health Research, and BC Cancer Foundation. W.D.F. thanks Ms. N. Wong for clinical contributions. We acknowledge the support provided by the following pathology labs: Perth Pathology, St John of God Pathology, Western Diagnostics, and PathWest (Royal Perth Hospital, Fremantle Hospital, King Edward Memorial Hospital, and Sir Charles Gairdner Hospital). The authors are very grateful to staff at the Australian Red Cross Blood Services for their assistance with the collection of risk factor information and blood samples of healthy donor control subjects and thank members of the QIMR Molecular Cancer Epidemiology Laboratory for their assistance with recruitment and biospecimen processing. This study was in part (P.S.M., U.R.) supported by the Intramural Research Program of the NIH. O.F.B. has been paid consultancy fees by Amgen and Sanofi Canada.